Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7064647 | PMC |
| http://dx.doi.org/10.1007/s13193-019-00982-x | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Clinical and Imaging Outcomes of Doxycycline Exchange Sclerotherapy for Lymphatic Malformations.
J Vasc Interv Radiol
December 2024
The Russell H. Morgan Department of Radiology and Radiological Science, The Johns Hopkins University School of Medicine, Baltimore, MD. Electronic address:
Purpose: To evaluate serial doxycycline exchanges (SDEs) to treat lymphatic malformations (LMs).
Materials And Methods: Retrospective chart review of patients undergoing LM sclerotherapy with SDEs at our tertiary care academic institution from April 2003 through March 2023. Primary outcome measure was change in symptoms between pre- and post-treatment clinical notes.
Recurrent Aneurysmal Bone Cyst Treated with Percutaneous Doxycycline Sclerotherapy: A Case Report.
JBJS Case Connect
October 2024
Cedars-Sinai Medical Center, Department of Orthopedic Surgery, Los Angeles, California.
Article Synopsis
- * After surgery, the cyst came back aggressively, prompting further intervention.
- * The recurrence was effectively treated using percutaneous doxycycline sclerotherapy, which is considered a low-risk option for such cases.
Outcome evaluation for the treatment of low flow venous and lymphatic malformations.
CVIR Endovasc
November 2024
George's Healthcare NHS Trust, St George's University Hospitals NHS Foundation Trust, London, SW17 0QT, UK.
Purpose: To propose a standardized method of subjectively and objectively evaluating outcomes of sclerotherapy in treating low flow vascular malformations.
Materials And Methods: Sixty-six patients with low flow vascular malformations (venous, lymphatic, or combined) were treated with percutaneous sclerotherapy using bleomycin, doxycycline, or sodium tetradecyl sulphate. Each lesion required between 2-5 sessions of sclerotherapy with 8-week intervals in between.
Outcome of Injection Sclerotherapy With Doxycycline in Lymphatic, and Veno-lymphatic Malformation in Children: A Single Centre Experience.
J Pediatr Surg
November 2024
Department of Paediatric Surgery, CHILDS Trust Medical Research Foundation, Kanchi Kamakoti CHILDS Trust Hospital, Chennai, India.
Aim: Lymphatic malformations (LMs) and Veno-lymphatic malformations (VLMs) are congenital slow flow vascular malformations. Intralesional sclerotherapy is a good alternate option for treatment of LMs and VLMs. Our aim was to evaluate the outcome of doxycycline sclerotherapy for lymphatic and veno-lymphatic malformation in children in our institute.
View Article and Find Full Text PDFDoxycycline Sclerotherapy of Mandibular Aneurysmal Bone Cysts: A Brief Clinical Study.
J Craniofac Surg
September 2024
Department of Radiology, Nationwide Children's Hospital, Columbus, OH.
Article Synopsis
- * This report discusses three pediatric cases where mandibular ABCs were effectively treated with image-guided doxycycline sclerotherapy, highlighting varying presentations and previous treatment experiences among the patients.
- * All patients showed resolution of symptoms and demonstrated successful bone healing without any functional or aesthetic complications, indicating that doxycycline sclerotherapy is a safe and effective treatment option for both new and recurring mandibular ABCs.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!